New insulin pump system tested for safety in toddlers and preschoolers with diabetes

NCT ID NCT06604871

Completed Disease control Sponsor: Medtronic MiniMed, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether the MiniMed 780G insulin pump, when used with a continuous glucose monitor, is safe for children aged 2 to 6 years with type 1 diabetes. Fifty-six children used the system at home. The main goals were to measure how often their blood sugar stayed in a healthy range and to track any serious side effects like severe low blood sugar or diabetic ketoacidosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MiniMed 780G insulin pump with DS5 continuous glucose monitor
What this could lead to: If successful, this could show that an automated insulin pump system is safe for very young children with type 1 diabetes, potentially improving their blood sugar control and reducing daily management burden.
What could go wrong: This is a small, completed safety study with only 56 children and no control group. It does not prove the system works better than other treatments, and risks like severe low blood sugar or device issues remain possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Barbara Davis Center for Childhood Diabetes

Aurora, Colorado, 80045, United States
Nemours Childrens Specialty Care

Jacksonville, Florida, 32207, United States
Stanford University

Palo Alto, California, 94304, United States
Texas Childrens Hospital

Houston, Texas, 77030, United States
UCSF The Madison Clinic for Pediatric Diabetes

San Francisco, California, 94158, United States
USF Diabetes and Endocrinology Center

Tampa, Florida, 33612, United States
University Hospitals Cleveland Medical Center

Cleveland, Ohio, 44106, United States
Yale School of Medicine

New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.